🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Futures kick off month on firm footing; economic data in focus

Published 2021-05-03, 07:25 a/m
© Reuters. A trader walks outside the New York Stock Exchange in  New York City
US500
-
MSFT
-
GOOGL
-
AAPL
-
AMZN
-
ESZ24
-
1YMZ24
-
NQZ24
-
GOOG
-

By Shreyashi Sanyal

(Reuters) - U.S. stock index futures rose on Monday after a week of largely upbeat earnings strengthened expectations of sustained profit growth at companies, with investors also awaiting economic data to gauge the pace of recovery.

With more than half of the S&P 500 companies already having reported results so far, profits are now expected to have risen 46% in the first quarter, compared with forecasts of 24% growth at the start of April, according to IBES data from Refinitiv.

Megacap technology stocks rose in premarket trading, with Apple Inc (NASDAQ:AAPL), Amazon.com Inc (NASDAQ:AMZN), Alphabet (NASDAQ:GOOGL) Inc and Microsoft Corp (NASDAQ:MSFT) adding between 0.2% and 0.4% after posting largely upbeat results in the prior week.

Improving economic data, strong earnings, fiscal stimulus and the Federal Reserve's ultra accommodative stance have supported markets, pushing the S&P 500 and the Nasdaq indexes to record levels during the course of last week.

Data on Monday is expected to show a slight rise in national factory activity, while a reading of the Labor Department's non-farm payrolls data was due to be released on Friday.

At 6:44 a.m. ET, Dow e-minis were up 216 points, or 0.64%, S&P 500 e-minis were up 22.25 points, or 0.53%, and Nasdaq 100 e-minis were up 35.25 points, or 0.25%.

Tesla Inc fell 0.9%. Industry sources told Reuters the electric vehicle maker, under scrutiny in China over safety and customer service complaints, is boosting its engagement with mainland regulators and beefing up its government relations team.

© Reuters. A trader walks outside the New York Stock Exchange in  New York City

Moderna Inc gained 2.4% after the drugmaker said it would supply 34 million doses of its COVID-19 vaccine this year to the global COVAX program.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.